Management View "We continue to make steady progress in our TakeAim Lymphoma study in primary CNS lymphoma" and said the TakeAi ...

Management attributes the increased net loss primarily to non-cash fair value adjustments of warrant liabilities from the ...

Thank you, and welcome to the Curis First Quarter 2026 Business Update Call. Before we begin, I'd like to encourag ...

Opportunities include identifying strategic regions for clinical trials, understanding enrollment trends, and analyzing trial success rates. The report aids investment strategies, saving time and cost ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...

MRD testing showed weak trial-level correlation with progression-free survival in BTK inhibitor and venetoclax-based CLL studies.

For BTK inhibitor selection in frontline CLL treatment, age, risk profile, and long-term sequencing strategy influence ...

Cleveland Browns owners recently made a large donation for cancer research. Dee Haslam lives daily with a rare blood cancer ...

Dee and Jimmy Haslam, the managing partners of Haslam Sports Group and owners of the Cleveland Browns, are putting serious ...

Browns owners Dee and Jimmy Haslam have donated $12.5 million toward blood cancer research after Dee was diagnosed with ...

Hulk Hogan’s former accountant is now facing federal charges for stealing more than $890,000 from an unidentified person in ...